Tuesday, April 15, 2025
Home Biotech News Exsosomes

Exsosomes

    Latest

    Heads Up! Big News on Stem Cells & Covid This Weekend.

    Stem Cells Editor / Curator -
    Gentlemen Start Your Research Engines! Be Fast and Be Early. We Could be Looking at a "Beam Me Up Scotty" Type Vector...
    Organicell

    Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.

    Superbug News - CoronaVirus Watch List Editor / Curator -
    Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what...
    Organicell

    Organicell (BPSR) a Triple Since Easter.

    Infections Editor / Curator -
    Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR)...
    Biotech Stock Review, Exsosomes

    Exosomes, Extracellular Vesicles, and the CoronaVirus.

    Biotech News Editor / Curator -
    Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS. Article #1:...

    Latest article

    Adding Allarity (ALLR) $0.70, to Watch List.

    2025 Watch List Editor / Curator -
    LIVE QUOTE SHORT TERM CHART Bargain Hunting? Adding to the...

    Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

    2025 Watch List Editor / Curator -
    This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...

    Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)

    All News Editor / Curator -
    Sorting Through the Wreckage! Full post on Investor's Business Daily. Biotech stocks took a beating Monday...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.